Technical Coverage on Health Care Stocks -- Research on Delcath Systems, Zimmer Holdings, St. Jude Medical, and ZELTIQ Aesthetics
PR Newswire - Fri May 09, 12:00PM CDT
On Thursday, May 08, 2014, the NASDAQ Composite ended at 4,051.50, down 0.40%, the Dow Jones Industrial Average finished the day 0.20% higher at 16,550.97, and the S&P 500 closed at 1,875.63, down 0.14%. During the trading session, five out of ten sectors finished positive. The S&P 500 Health Care Sector Index closed the day at 664.48, down 0.53%, while the index has advanced 0.78% in the last one month. Investor-Edge has initiated coverage on the following equities: Delcath Systems Inc. (NASDAQ: DCTH), Zimmer Holdings Inc. (NYSE: ZMH), St. Jude Medical Inc. (NYSE: STJ) and ZELTIQ Aesthetics Inc. (NASDAQ: ZLTQ). Free technical research on DCTH, ZMH, STJ and ZLTQ can be downloaded upon signing up at:
Insider Trading Alert - ORLY, INFN And ZLTQ Traded By Insiders
at The Street - Fri May 02, 10:30AM CDT
Stocks with insider trader activity include ORLY, INFN and ZLTQ
Why Zeltiq Aesthetics Inc. Shares Slipped
Sean Williams, The Motley Fool - Motley Fool - Wed Apr 30, 2:58PM CDT
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: Shares of Zeltiq Aesthetics , a medical technology...
Why Zeltiq Aesthetics (ZLTQ) Stock Is Falling Today
at The Street - Wed Apr 30, 2:54PM CDT
Zeltiq Aesthetics (ZLTQ) is down after missing analysts earnings and revenue guidance in its first quarter.
ZELTIQ Announces First Quarter 2014 Financial Results
Marketwire - Tue Apr 29, 3:08PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ)
Live CoolSculpting(R) Demonstration With New CoolSmooth(TM) Applicator at the Aesthetic Meeting 2014
Marketwire - Thu Apr 24, 7:02AM CDT
ZELTIQ(R) Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced it is exhibiting at The Aesthetic Meeting, organized by the American Society for Aesthetic Surgery (ASAPS), in San Francisco, April 24-29, 2014. Developed by ZELTIQ, the CoolSculpting procedure is a non-surgical, clinically proven procedure designed to selectively reduce fat in treated areas using a patented cooling technology. Live CoolSculpting treatments will be performed in the company's booth using the newly launched CoolSmooth applicator, which delivers surface-based cooling to treat non-pinchable fat bulges in areas such as the outer thigh.
ZELTIQ Announces Conference Call and Webcast of First Quarter 2014 Financial Results to Be Held on April 29, 2014
Marketwire - Tue Apr 15, 3:06PM CDT
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, announced today that it plans to release its first quarter 2014 financial results on Tuesday, April 29, 2014 after the market close.
Relief for "Thigh Shy" Consumers: CoolSculpting(R) Receives FDA Clearance for Non-Surgical Reduction of Thigh Fat
Marketwire - Mon Apr 14, 7:31AM CDT
ZELTIQ(R) Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced that the CoolSculpting procedure has received U.S. Food and Drug Administration (FDA) clearance to treat the thighs with its entire suite of applicators. The CoolSculpting procedure is clinically proven to non-surgically reduce unwanted fat, and is already FDA cleared to treat the abdomen and flanks.
ZELTIQ Announces FDA Clearance to Treat Thighs
Marketwire - Mon Apr 14, 7:30AM CDT
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced it has received U.S. Food and Drug Administration (FDA) clearance to treat the thigh area with its entire suite of applicators. The CoolSculpting procedure is a clinically proven, non-surgical procedure that reduces fat in the treated area for good, and is already FDA cleared to treat the abdomen and flanks.
Financial Results Schedules, Approvals, Appointments, Product Launches, and Stock Movements - Analyst Notes on Allergan, Accuray, Cerus, Galena Biopharma, and ZELTIQ Aesthetic
PR Newswire - Wed Apr 09, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Allergan Inc. (NYSE: AGN), Accuray Incorporated (NASDAQ: ARAY), Cerus Corporation (NASDAQ: CERS), Galena Biopharma, Inc. (NASDAQ: GALE), and ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
ZELTIQ Aesthetics expands its CoolSculpting fat reduction treatment procedure, with launch of new CoolSmooth system
M2 - Mon Mar 24, 3:56AM CDT
Medical technology company ZELTIQ Aesthetics (NASDAQ:ZLTQ) reported on Friday the global launch of its CoolSmooth applicator at the American Academy of Dermatology (AAD) annual meeting in Denver, Colorado, for the non-invasive fat reduction in the abdomen and flank.
ZELTIQ(R) Aesthetics Launches CoolSmooth(TM) Applicator
Marketwire - Fri Mar 21, 7:00AM CDT
ZELTIQ Aesthetics, Inc. (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology, today announced the global introduction of the CoolSmooth applicator, the latest addition to the applicator platform for the CoolSculpting system, at the American Academy of Dermatology (AAD), annual meeting in Denver, Colo. The CoolSmooth applicator features non-vacuum based cooling that easily treats non-pinchable fat bulges, and the comfortable design adjusts to fit each individual patient.
Nasdaq stocks posting largest percentage decreases
AP - Mon Mar 10, 5:09PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at the close of trading:
3 Predictions for the New Week
Rick Munarriz, The Motley Fool - Motley Fool - Sun Mar 02, 2:00PM CST
I went out on a limb last week , and now it's time to see how that decision played out. I predicted that ZELTIQ Aesthetics would move higher on the week. The company behind the gut-thinning CoolSculpting machines spent all of 2013 boosting...
ZELTIQ to Present at 26th Annual ROTH Conference
Marketwire - Wed Feb 26, 3:05PM CST
ZELTIQ(R) (NASDAQ: ZLTQ), a medical technology company focused on developing and commercializing products utilizing its proprietary controlled-cooling technology platform, today announced that Mark Foley, President and Chief Executive Officer, and Patrick F. Williams, Senior Vice President and Chief Financial Officer, are scheduled to present at the 26th Annual ROTH Conference at the Ritz Carlton in Laguna Niguel, California.
ZELTIQ Aesthetics Announces Fourth Quarter and Full Year 2013 Financial Results
Marketwire - Tue Feb 25, 3:01PM CST
ZELTIQ(R) (NASDAQ: ZLTQ)
10-K: ROPER INDUSTRIES INC
Edgar Online - Fri Feb 21, 2:51PM CST
ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS